Rudnick MR - Search Results

1

Tobacco Use: A Chronic Kidney Disease Accelerant.

Leonberg-Yoo AK, Rudnick MR. Leonberg-Yoo AK, et al. Among authors: rudnick mr. Am J Nephrol. 2017;46(4):257-259. doi: 10.1159/000481209. Epub 2017 Sep 21. Am J Nephrol. 2017. PMID: 28930748 Free article. No abstract available.

2

The Controversy of Contrast-Induced Nephropathy With Intravenous Contrast: What Is the Risk?

Rudnick MR, Leonberg-Yoo AK, Litt HI, Cohen RM, Hilton S, Reese PP. Rudnick MR, et al. Am J Kidney Dis. 2020 Jan;75(1):105-113. doi: 10.1053/j.ajkd.2019.05.022. Epub 2019 Aug 28. Am J Kidney Dis. 2020. PMID: 31473019 Review.

3

Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review.

Rudnick MR, Wahba IM, Leonberg-Yoo AK, Miskulin D, Litt HI. Rudnick MR, et al. Am J Kidney Dis. 2021 Apr;77(4):517-528. doi: 10.1053/j.ajkd.2020.07.012. Epub 2020 Aug 27. Am J Kidney Dis. 2021. PMID: 32861792 Review.

4

Use of Gadolinium-Based Contrast Agents in Patients with Severe Renal Impairment. Absence of Risk Versus Caution: A Nephrologist's Perspective.

Rudnick MR, Wahba IM, Leonberg-Yoo AK. Rudnick MR, et al. Kidney360. 2020 Jun 25;1(6):433-435. doi: 10.34067/KID.0003022020. eCollection 2020 Jun 25. Kidney360. 2020. PMID: 35368601 Free PMC article. No abstract available.

5

Use of Radiocontrast Agents in CKD and ESRD.

Bahrainwala JZ, Leonberg-Yoo AK, Rudnick MR. Bahrainwala JZ, et al. Among authors: rudnick mr. Semin Dial. 2017 Jul;30(4):290-304. doi: 10.1111/sdi.12593. Epub 2017 Apr 5. Semin Dial. 2017. PMID: 28382626 Review.

6

Bilateral Renal Infarctions During the Use of Sumatriptan.

Abramovitz B, Leonberg-Yoo A, Bahrainwala JZ, Litt H, Rudnick MR. Abramovitz B, et al. Among authors: rudnick mr. Kidney Int Rep. 2018 May 16;3(5):1233-1236. doi: 10.1016/j.ekir.2018.05.003. eCollection 2018 Sep. Kidney Int Rep. 2018. PMID: 30197992 Free PMC article. No abstract available.

7

Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial.

Rudnick MR, Davidson C, Laskey W, Stafford JL, Sherwin PF; VALOR Trial Investigators. Rudnick MR, et al. Am Heart J. 2008 Oct;156(4):776-82. doi: 10.1016/j.ahj.2008.05.023. Am Heart J. 2008. PMID: 18946896 Clinical Trial.

8

Acute Kidney Injury in COVID-19: Another Challenge for Nephrology.

Rudnick MR, Hilburg R. Rudnick MR, et al. Am J Nephrol. 2020;51(10):761-763. doi: 10.1159/000511161. Epub 2020 Oct 15. Am J Nephrol. 2020. PMID: 33059350 Free PMC article. No abstract available.

9

Renal failure in patients with left ventricular assist devices.

Patel AM, Adeseun GA, Ahmed I, Mitter N, Rame JE, Rudnick MR. Patel AM, et al. Among authors: rudnick mr. Clin J Am Soc Nephrol. 2013 Mar;8(3):484-96. doi: 10.2215/CJN.06210612. Epub 2012 Oct 11. Clin J Am Soc Nephrol. 2013. PMID: 23065497 Review.

10

A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis.

Berns JS, Rudnick MR, Cohen RM. Berns JS, et al. Among authors: rudnick mr. Clin Nephrol. 1992 May;37(5):264-7. Clin Nephrol. 1992. PMID: 1606777 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters